Document and Entity Information
Document and Entity Information | Oct. 13, 2023 |
Document and Entity Information [Abstract] | |
Document Type | 8-K/A |
Document Period End Date | Oct. 13, 2023 |
Entity File Number | 001-39712 |
Entity Registrant Name | Olema Pharmaceuticals, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 30-0409740 |
Entity Address, Address Line One | 780 Brannan Street |
Entity Address, City or Town | San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94103 |
City Area Code | 415 |
Local Phone Number | 651-3316 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.0001 par value per share |
Trading Symbol | OLMA |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001750284 |
Amendment Flag | true |
Amendment Description | This Form 8-K/A is being filed to amend the Current Report on Form 8-K of Olema Pharmaceuticals, Inc., filed with the Securities and Exchange Commission on October 17, 2023 (the “Original Form 8-K”), to correct a typographical error and the Item number under which the information was reported. This Form 8-K/A amends and restates in its entirety the Original Form 8-K. Other than the aforementioned corrections, the remainder of the Original Form 8-K remains unchanged. |